The importance of outsourcing regulatory solutions
The pharmaceutical industry is one that faces constant change across all its areas. Whether it’s the impact of geopolitical movements such as Brexit, incorporation of new technology, or ever-changing regulations that create challenges for marketing authorization holders. Pharmaceutical businesses are increasingly outsourcing regulatory affairs as they do not have the infrastructure or resources in place for regulatory operations, and want to maximize the efficiency of their processes. Outsourcing regulatory solutions is becoming a common and successful practice for businesses; even for larger organizations that have regulatory divisions in place, they face new challenges when entering emerging or novel markets.
Both small and large companies establish a
relationship with outsourcing service providers for a variety of regulatory services to
minimize cost and maximize resources to drive the business forward. This can
include medico-regulatory writing, literature searches, compilation of
regulatory documents, and compliance-based processes from drafting and
implementing standard operating procedures (SOPs) to conducting audits of
organizations and pharmacovigilance systems. Additionally, pharmaceutical
businesses look to outsource liaising activities with global regulatory authorities, developing regulatory strategies,
regulatory intelligence and more. Successful outsourcing requires
pharmaceutical businesses to correctly identify partners that can not only
provide the technical expertise but also be reliable and transparent in their
ways of working.
Outsourcing regulatory
services is the preferred choice for large and small organizations. However, it
is crucial for them to ensure that the service providers they choose to partner
with are qualified, experienced, and knowledgeable on their regulatory
services, the regulatory market, and the importance of maintaining regulatory
compliance.
Regulations and legislations surrounding
pharmaceutical products are becoming more stringent, creating delays in
achieving market authorizations. DDReg provides end-to-end regulatory services
to obtain rapid market access for Rx Generic, OTC/GSL Medicines, Biosimilars
and vaccines. We have managed regulatory compliance for 2000+ licenses globally
and delivered 200+ authorizations in the EU & the US, and 600+ MAs in
emerging markets including GCC, Africas, LatAm, CIS & ASEAN. Furthermore,
we have a highly qualified pharmacovigilance team that ensures regulatory
compliance along the entire product lifecycle and ensures robust
pharmacovigilance measures are in place for the organization.
Comments
Post a Comment